This 45-minute live webinar series will educate participants on issues considered by the NCCN Guidelines Panel resulting in the recent update to the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC). These issues include, but are not limited to, a comparison of new data with existing standards of care, involved patient subsets, and risk-benefit analysis in the diagnosis and treatment of the disease as well as a review of the significant studies that supported modification of the panels' recommendations
Jeden z online seminářů NCCN tematicky zaměřených na genitourinární nádory
Konference vytváří interdisciplinární platformu pro spolupráci odborníků z řady teoretických, preklinických a klinických oborů zabývajících se diagnostikou a léčbou maligních nádorů.
Jeden z online seminářů NCCN tematicky zaměřených na genitourinární nádory
This 45-minute live webinar series will educate participants on issues considered by the NCCN Guidelines Panel resulting in the recent update to the NCCN Guidelines for Kidney Cancer. These issues include, but are not limited to, a comparison of new data with existing standards of care, involved patient subsets, and risk-benefit analysis in the diagnosis and treatment of the disease as well as a review of the significant studies that supported modification of the panels' recommendations.
This full-day Congress is designed to provide education on the clinical and policy needs of the pharmacist involved in the treatment of patients with cancer. This program will include the following sessions: Impact of Risk Evaluation and Mitigation Strategies (REMS) in Practice, Venous Thromboembolism (VTE) and Anticoagulation for the Patient with Cancer, Best Practices in Implementing Computer Order Entry Systems, Updates in Supportive Care, Management of Product Shortages Affecting Oncology Care, and Cost Containment Strategies.
